Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs)
β Scribed by Chao Wan; Qiling He; Mervyn McCaigue; David Marsh; Gang Li
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 303 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
To obtain enough quantity of osteogenic cells is a challenge for successful cell therapy in bone defect treatment, and cell numbers were usually achieved by culturing bone marrow cells in a relatively long duration. This study reports a simple and costβeffective method to enhance the number of mesenchymal stem cells (MSCs) by collecting and replating the nonadherent cell population of marrow MSCs culture. Bone marrow MSCs were isolated from 11 patients, cultured at a density of 1βΓβ10^5^/cm^2^ to 1βΓβ10^6^/cm^2^ in flasks. For the first three times of media change, the floating cells were centrifuged and replated in separate flasks. The total number of cells in both the primary and replating flasks were counted at day 21. Cell proliferation rate, potentials for osteogenic, chondrognenic, and adipogenic differentiation were examined in both cell types in vitro. In vivo osteogenic potentials of the cells were also tested in mice implantation model. The results showed that MSCs derived from nonadherent cell population of marrow cell cultures have similar cell proliferation and differentiation potentials as the originally attached MSCs in vitro. When implanted with hydroxyapatite/tricalcium phosphate (HAβTCP) materials subcutaneously in serve combined immune deficiency (SCID) mice, newly formed bony tissues were found in both cell type groups with osteocalcin expression. We have obtained 36.6% (20.70%β44.97%) more MSCs in the same culture period when the nonadherent cell populations were collected. The findings confirmed that the nonadherent cell population in the bone marrow culture is a complementary source of MSCs, collecting these cells is a simple and costβeffective way to increase MSCs numbers and reduce the time required for culturing MSCs for clinical applications. Β© 2005 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res
π SIMILAR VOLUMES
## Abstract Mesenchymal stem cells derived from human bone marrow (hBMβMSCs) can differentiate into chondrogenic cells for the potential treatment of injured articular cartilage. To evaluate agarose gels as a supportive material for chondrogenesis of hBMβMSCs, this study examined chondrogenesis of
## Abstract Human mesenchymal stem cells (hMSCs) may be used for therapeutic applications. Culture conditions such as the serum source may impact on cell quality and the onset of replicative senescence. We have examined the effect of culturing hMSCs in autologous serum (AS) versus fetal bovine seru